Metraipolis › archive › dc_7d455e967958
Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitors — Europe PMC PMID:41026530
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41026530
- DOI
- 10.1172/jci.insight.192984
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T17:09:17.468Z
- SHA-256 of the archived text
e7814d095d607f32892e2dede28e2cd1a34e225135f48ec5818f14521bb7ef07- Stable URL of this page
https://metraipolis.com/documento/dc_7d455e967958
How to cite
Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitors — Europe PMC PMID:41026530 — Europe PMC (en), https://europepmc.org/article/MED/41026530 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d455e967958 (Metraipolis archive dc_7d455e967958, sha256 e7814d095d607f32892e2dede28e2cd1a34e225135f48ec5818f14521bb7ef07)
BibTeX
@misc{dc7d455e967958,
title = {Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitors — Europe PMC PMID:41026530},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41026530},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d455e967958; sha256 e7814d095d607f32892e2dede28e2cd1a34e225135f48ec5818f14521bb7ef07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026530. Agents can read the archived copy with the MCP tool read_document.